Clinical Trial Update: Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction [NA]

View source ↗

Summary

A terminated clinical safety study evaluating transmyocardial revascularization using bone marrow aspirate (BMAC) for angina relief; no further results reported…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• Transmyocardial Revascularization with Bone Marrow Aspirate (BMAC) (bone marrow aspirate with transmyocardial revascularization)

Snippet

Sponsor: Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. | Conditions: Angina | NA | Status: TERMINATED